DF
DC Funds, LP
13F filer · CIK 0001869028Reported Aug 14, 2026
13F portfolio value$1.25MU.S. long equity reported on 13F
Positions3Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20263 positions | |||||
| $617K | 49.27% | 2.63% | Not reported | Q3 2021 | |
| BBBRNSBarinthus Biotherapeutics plc. | $424K | 33.82% | 1.57% | Not reported | Q2 2021 |
| $212K | 16.92% | 1.21% | Not reported | Q2 2021 | |
| Q1 2026Reported May 14, 20263 positions | |||||
| $630K | 42.40% | 2.63% | Not reported | Q3 2021 | |
| $490K | 33.01% | 1.21% | Not reported | Q2 2021 | |
| BBBRNSBarinthus Biotherapeutics plc. | $365K | 24.59% | 1.57% | Not reported | Q2 2021 |
| Q4 2025Reported Feb 13, 20263 positions | |||||
| $630K | 43.36% | 2.63% | Not reported | Q3 2021 | |
| BBBRNSBarinthus Biotherapeutics plc. | $450K | 30.95% | 1.57% | Not reported | Q2 2021 |
| $373K | 25.69% | 1.21% | Not reported | Q2 2021 | |
| Q3 2025Reported Nov 10, 20253 positions | |||||
| $1.16M | 37.32% | 1.25% | Not reported | Q2 2021 | |
| $1.15M | 36.87% | 2.63% | Not reported | Q3 2021 | |
| BBBRNSBarinthus Biotherapeutics plc. | $803K | 25.81% | 1.57% | Not reported | Q2 2021 |
Premium opens every quarter this fund has filed